Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
misiu143's Profile
Displaying 1-50 of 4446 result(s).
CYDY CytoDyn Inc
05/12/2025 11:18:33 AM
I agree with you Jeff . Treating so (19)
CYDY CytoDyn Inc
05/08/2025 1:09:00 PM
Great post from IHUB.. easy explana (26)
CYDY CytoDyn Inc
05/08/2025 9:21:46 AM
Right , and 3-4 years later , we st (9)
CYDY CytoDyn Inc
05/08/2025 9:08:45 AM
Biloxi, And I will always think ver (20)
CYDY CytoDyn Inc
05/08/2025 8:55:16 AM
I am sure you know , all of those p (11)
CYDY CytoDyn Inc
05/08/2025 8:26:00 AM
Well , sorry .. Great .. I actually (7)
CYDY CytoDyn Inc
05/08/2025 7:31:49 AM
Ohm , thank you for all the great a (20)
CYDY CytoDyn Inc
05/08/2025 6:55:33 AM
Ken this is exactly right , because (7)
CYDY CytoDyn Inc
05/08/2025 6:45:53 AM
I can’t give you numbers , but im (9)
CYDY CytoDyn Inc
05/07/2025 5:47:24 PM
What I know dostarlimab is mostly t (11)
CYDY CytoDyn Inc
05/07/2025 3:05:17 PM
Glioblastoma , imo , is not yet con (9)
CYDY CytoDyn Inc
05/07/2025 1:53:59 PM
Katangolo , we will have most proba (30)
CYDY CytoDyn Inc
05/07/2025 7:44:17 AM
They both looking on a different th (6)
CYDY CytoDyn Inc
05/07/2025 7:21:08 AM
Ohm , Protocol for a trial may go f (4)
CYDY CytoDyn Inc
05/06/2025 2:44:18 PM
December 2024, " .protocol is final (2)
CYDY CytoDyn Inc
05/06/2025 2:20:42 PM
Sean , it would be OK , most probab (2)
CYDY CytoDyn Inc
05/06/2025 12:41:24 PM
I was in Central NJ , went to Balti (13)
CYDY CytoDyn Inc
05/06/2025 11:20:52 AM
Ohm, I only know the facts I am rea (15)
CYDY CytoDyn Inc
05/06/2025 10:55:40 AM
Ken , all what is important now for (3)
CYDY CytoDyn Inc
05/06/2025 10:28:51 AM
And from March of 2025 letter .. " (9)
CYDY CytoDyn Inc
05/06/2025 9:37:21 AM
That is not really important , our (4)
CYDY CytoDyn Inc
05/06/2025 9:28:12 AM
Hi Biloxi , late but we are hopeful (7)
CYDY CytoDyn Inc
05/06/2025 9:24:21 AM
No Ken I cant agree here ... They c (5)
CYDY CytoDyn Inc
05/06/2025 9:18:25 AM
That is exactly right , taking 15 m (5)
CYDY CytoDyn Inc
05/06/2025 9:07:18 AM
Yes , but Cornell is not paying for (7)
CYDY CytoDyn Inc
05/06/2025 8:30:13 AM
Ohm, what Gov has to do with our Al (13)
CYDY CytoDyn Inc
04/30/2025 1:44:02 PM
Great question , and a comments .. (6)
CYDY CytoDyn Inc
04/29/2025 3:25:54 PM
Exactly mTNBC ...
CYDY CytoDyn Inc
04/29/2025 3:01:55 PM
I believe all patients we treat wit (2)
CYDY CytoDyn Inc
04/29/2025 10:53:29 AM
True, In our phase 1b/2 trial , fir (12)
CYDY CytoDyn Inc
04/29/2025 10:17:01 AM
28 patients. --10 patients from our (13)
CYDY CytoDyn Inc
04/16/2025 4:06:42 PM
I am very surprised Europe approved (12)
CYDY CytoDyn Inc
04/03/2025 6:20:07 PM
Your logic I do understand , but ye (1)
CYDY CytoDyn Inc
04/03/2025 2:23:41 PM
Yes , just one thing... We the only (16)
CYDY CytoDyn Inc
04/01/2025 6:43:18 PM
I knew that , working for some phar (3)
CYDY CytoDyn Inc
04/01/2025 6:30:54 PM
Few hrs ago I send an email to Dr J (10)
CYDY CytoDyn Inc
04/01/2025 6:24:56 PM
You are right , team should never m (1)
CYDY CytoDyn Inc
04/01/2025 5:07:31 PM
Cardamine , I am much more hopeful (4)
CYDY CytoDyn Inc
04/01/2025 4:53:41 PM
It is hard to believe Dr Jeff Murra (26)
CYDY CytoDyn Inc
04/01/2025 4:26:11 PM
I too am very excited to have Dr Ma (16)
CYDY CytoDyn Inc
04/01/2025 12:04:02 PM
True , company is providing informa (3)
CYDY CytoDyn Inc
04/01/2025 10:59:49 AM
Actually it is written phase 2 , an (2)
CYDY CytoDyn Inc
04/01/2025 10:50:35 AM
How is this possible ? we didn’t (3)
CYDY CytoDyn Inc
04/01/2025 10:41:39 AM
Clinical trials.gov says phase 2 fo (2)
CYDY CytoDyn Inc
03/30/2025 10:44:27 AM
This is an official poster presenta (13)
CYDY CytoDyn Inc
03/30/2025 10:04:13 AM
They should publish results from th (11)
CYDY CytoDyn Inc
03/25/2025 9:36:29 PM
This video is from 2019 . (3)
CYDY CytoDyn Inc
03/25/2025 8:21:49 PM
Brentle , I though you are joking y (11)
CYDY CytoDyn Inc
03/21/2025 1:23:43 PM
Yes , when his MiL started monother (13)
CYDY CytoDyn Inc
03/20/2025 7:17:10 PM
No it is not , it was change as soo (10)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Perimeter Acquisition Corp. I Plans Significant IPO to Fund Growth
  • Apimeds Pharmaceuticals Celebrates Successful Public Offering Launch
  • Village Farms Enters Joint Venture to Private Fresh Produce Sector
  • Legacy Housing Corporation Announces First Quarter Results
  • Village Farms International: Q1/25 Financial Performance Insights
  • Major Resource Assessment Boost at Shaakichiuwaanaan Project
  • Quarterhill Annual Meeting Unveils Key Decisions and Plans
  • Galiano Gold Unveils 2024 Environmental and Social Progress
  • Investigation Insights for Investors of Cleveland-Cliffs Inc.
  • Cable One Faces Investigations Amid Financial Disappointments
  • Investigation into Ardelyx, Inc. for Investor Protection
  • PTC Therapeutics Faces Investigation Amid Stock Price Drop
  • Krispy Kreme Faces Investigation Amid Revenue Decline Concerns
  • Investor Insights: Capricor Therapeutics Faces Class Action Scrutiny
  • Investors Gather as Arvinas, Inc. Faces Legal Challenges
  • Compass Diversified Faces Investigation Amid Financial Turmoil
  • Take-Two Interactive Faces Legal Scrutiny Over Recent Developments
  • Top Mobile Gaming Apps Ranked for Quality by Pixalate
  • SelectQuote Faces Scrutiny Amid Allegations and Stock Plunge
  • Exploring the Leading Sports Apps for Advertisers in 2025
  • Investigation into GoHealth, Inc. Sparks Investor Concerns
  • Investor Alert: Navigating Recent Legal Claims Against Humana
  • 3D Systems First Quarter Earnings Showcase Challenges and Strengths
  • Investor Insights: Bausch + Lomb Faces Scrutiny Over Stock Drop
  • Wabash National Corporation Faces Investigation Amid Losses
  • Microvast's Impressive Financial Growth in Q1 2025 Revealed
  • Cheer Holding, Inc. Shares Insights from Its Annual Meeting
  • Quipt Home Medical's Promising Trends Amid Q2 Financial Results
  • GINSMS Reports Q1 Financial Performance: Opportunities Ahead
  • Anika Reports New Stock Option Grants for Employee Incentives
  • Copa Holdings Reports Growth in Passenger Traffic for April
  • Constellation Software Reports Strong Q1 Growth and Dividend
  • iAnthus Capital Holdings: A Closer Look at Q1 Financials
  • Heritage Commerce Corp Secures KBRA Ratings with Stable Outlook
  • NIP Group Inc. Publishes Comprehensive Annual Report for 2024
  • BeyondSpring Inc. Marks Milestones in Q1 Financial Performance
  • Vital Energy Reveals Strong First-Quarter Financials
  • ZyVersa Therapeutics: Q1 2025 Financial Overview and Updates
  • Oxbridge Re's Tokenized Reinsurance Sector Expansion in 2025
  • Perspective Therapeutics: Accelerating Cancer Innovations with Updates
  • Context Therapeutics Strengthens Team with Inducement Grants
  • Team, Inc. Shows Strategic Growth in Q1 Financials
  • Long-Term Benefits of TransCon® PTH Therapy in Adults Unveiled
  • Key Proposals for Ensurge Micropower ASA’s AGM Upcoming
  • AirJoule Technologies Reports Key Q1 2025 Performance Insights
  • Pangaea Logistics Solutions Releases Q1 2025 Financial Insights
  • Globe Life Unveils New Ballfield at Youth Sports Complex
  • Newlab's Expansion: Catalyzing Energy Innovation in Louisiana
  • WhiteHorse Finance Reports Strong Q1 Results and $0.385 Distribution
  • Revolutionizing Gaming: DX Terminal's Futuristic Simulation
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site